Valuation: LifeVantage Corporation

Market Cap 80.11M 70.39M 65.71M 60.3M 113M 7.67B 116M 779M 305M 3.8B 301M 294M 13.13B P/E 2026 *
15.1x
P/E 2027 * 16.3x
Enterprise Value 66.56M 58.49M 54.59M 50.1M 93.79M 6.38B 96.1M 647M 253M 3.15B 250M 244M 10.91B EV / Sales 2026 *
0.36x
EV / Sales 2027 * 0.37x
Free-Float
87.97%
Yield 2026 *
-
Yield 2027 * -
1 day-2.05%
1 week+0.32%
Current month+0.80%
1 month+0.80%
3 months+24.55%
6 months+18.68%
Current year+2.11%
1 week 6.21
Extreme 6.21
6.61
1 month 5.82
Extreme 5.82
6.61
Current year 3.9
Extreme 3.9
11.71
1 year 3.9
Extreme 3.9
15
3 years 3.9
Extreme 3.9
27.38
5 years 3.04
Extreme 3.04
27.38
10 years 2.86
Extreme 2.86
27.38
Manager TitleAgeSince
Chief Executive Officer 74 30/04/2026
Director of Finance/CFO 53 25/10/2021
Chief Tech/Sci/R&D Officer - 07/01/2026
Director TitleAgeSince
Director/Board Member 74 01/01/2012
Director/Board Member 67 01/02/2017
Director/Board Member 68 17/02/2022
Date Insider Type Main position Quantity % Market Cap.
7/1/26 A Tax

Chief Financial Officer

-1,361 0.0108%
7/1/26 A Tax

Responsable ventes & marketing

-1,717 0.0136%
7/1/26 A Tax

General Counsel

-1,342 0.0106%
Change 5-day change 1-year change 3-year change Capi.($)
-2.05%+0.32%-50.55%+24.31% 80.11M
-4.15%-1.68%+53.40%+156.50% 1,079B
-4.09%-1.28%+53.02%+52.77% 640B
-3.33%-0.12%+35.55%+71.55% 465B
-2.35%+0.92%+35.86%+30.34% 353B
-2.24%-0.55%+33.61%+39.41% 301B
-2.90%+0.71%+11.13%+14.23% 271B
-2.08%+3.09%+1.60%-39.53% 228B
-2.31%+2.41%+26.25%+62.49% 209B
-3.32%-1.03%+12.85%+70.09% 165B
Average -2.78%+2.62%+21.27%+48.22% 370.98B
Weighted average by Cap. -3.21%+1.42%+38.23%+74.92%

Financials

2026 *2027 *
Net sales 184M 162M 151M 139M 260M 17.64B 266M 1.79B 701M 8.73B 692M 677M 30.18B 178M 157M 146M 134M 251M 17.09B 258M 1.73B 678M 8.45B 670M 655M 29.23B
Net income 5.3M 4.66M 4.35M 3.99M 7.47M 508M 7.65M 51.55M 20.16M 251M 19.9M 19.47M 868M 4.9M 4.31M 4.02M 3.69M 6.9M 469M 7.07M 47.66M 18.64M 232M 18.4M 18M 803M
Net Debt -13.55M -11.91M -11.11M -10.2M -19.09M -1.3B -19.56M -132M -51.54M -642M -50.87M -49.77M -2.22B -15M -13.18M -12.3M -11.29M -21.13M -1.44B -21.65M -146M -57.03M -711M -56.3M -55.08M -2.46B
Logo LifeVantage Corporation
LifeVantage Corporation is an activation company, which is engage in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, weight management products, pre- and pro-biotics, skin and hair care products, and nootropics. The Company’s line of scientifically validated activators includes the flagship Protandim family of products, TrueScience Liquid Collagen, the newest MindBody GLP-1 System, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System , as well as AXIO nootropic energy drink mixes, the full TrueScience line of skin and hair care products, and Petandim, a pet supplement formulated to combat oxidative stress in dogs. It sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand and Singapore.
Employees
235
Date Price Change Volume
30/07/26 $6.275 -1.18% 6,748
29/07/26 $6.350 -1.24% 67,183
28/07/26 $6.430 +0.94% 77,842
27/07/26 $6.370 -2.45% 75,142
24/07/26 $6.530 +4.15% 57,611
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
6.350USD
Average target price
7.000USD
Spread / Average Target
+10.24%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LFVN Stock